Skip to main content

Month: September 2021

Allarity Therapeutics Receives Approximately SEK 16.5 Million (US $1.9 Million) from Subscription to Warrants of Series ALLR TO 3

 Subscription is approximately 6.7 percent of total outstanding TO 3 warrants Allarity’s Chairman of the Board and largest shareholder (Sass & Larsen ApS) participated in the subscriptionPress Release Hørsholm, Denmark (September 14, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announces the outcome of the exercise of the warrants of series ALLR TO 3 that were issued in connection with the Company’s issue of units in June 2021. In total, 9,719,266 warrants of series TO 3 were exercised, corresponding to approximately 6.7 percent of the total number of outstanding warrants, for subscription of 9,719,266 shares at a subscription price of SEK 1.7 per share. Through the exercise of the warrants, Allarity will receive approximately SEK 16.5 million (U.S. $1.9 million) before issuing costs amounting to approximately...

Continue reading

Onex Partners and BPEA Complete Offering of Clarivate Shares

All amounts in U.S. dollars unless otherwise stated TORONTO and HONG KONG, Sept. 14, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX), Baring Private Equity Asia (“BPEA”) and their affiliated funds (together the “Group”), today announced they have sold 25 million ordinary shares of Clarivate plc (“Clarivate”) (NYSE: CLVT) at a price of $25.25 per share. In addition, the underwriters were granted a 30-day option to purchase up to 3.75 million ordinary shares from the Group. Clarivate is a global leader in providing trusted information and insights to accelerate the pace of innovation. At the purchase price and before the underwriters’ option, net proceeds to the Group were approximately $630 million, of which Onex’ share was approximately $120 million as a Limited Partner in Onex Partners IV and as a co-investor. The...

Continue reading

AMREP Reports First Quarter Fiscal 2022 Results

HAVERTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $1,637,000, or $0.22 per diluted share, for its 2022 fiscal first quarter ended July 31, 2021 compared to net income of $593,000, or $0.07 per diluted share, for the same period of the prior year.   Revenues were $10,507,000 for the first quarter of 2022 and $4,206,000 for the first quarter of 2021. More information about the Company’s financial performance for the first quarters of 2022 and 2021 may be found in AMREP Corporation’s financial statements on Form 10-Q which have today been filed with the Securities and Exchange Commission and will be available on AMREP’s website (www.amrepcorp.com/sec-filings/). AMREP Corporation, through its subsidiaries, is a major holder of land, leading developer of real estate and award-winning...

Continue reading

Altus Group Announces C$150 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry, announced today that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by bookrunners TD Securities Inc. and BMO Capital Markets, under which the Underwriters have agreed to buy on a bought deal basis 2,420,000 common shares in the capital of the Company (the “Common Shares”), at a price of $62.00 per Common Share (the “Offering Price”) for gross proceeds of approximately $150 million (the “Offering”). The Company has granted the Underwriters an option, exercisable at the...

Continue reading

Verizon to offer all-new iPhone 13 lineup, iPad and iPad mini with orders starting 9/17

Current and new Verizon customers can get an iPhone 13 on us with select trade-in on select Unlimited plans1 BASKING RIDGE, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) — Verizon will offer the best-ever lineup of iPhone and iPad, including the innovative and elegant iPhone 13 Pro, iPhone 13 Pro Max, iPhone 13, and iPhone 13 mini, the highly capable and affordable iPad (9th generation) and iPad mini with a new all-screen design. Redesigned inside and out, iPhone 13 Pro and iPhone 13 Pro Max introduce the most advanced pro camera system ever on iPhone, Super Retina XDR display with ProMotion, improved battery life, the Apple-designed A15 Bionic chip with 5-core GPU and an advanced 5G experience. iPhone 13 and iPhone 13 mini feature the most advanced dual camera system ever in iPhone and the powerhouse A15 Bionic chip in a sleek and durable...

Continue reading

Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the Cantor Virtual Global Healthcare Conference on Thursday, September 30 from 10:40-11:10am ET. Checkmate will also host 1×1 investor meetings during the conference. The webcast can be accessed under “Events & Presentations” in the Investors section of the Checkmate website. An archived copy of the webcast will be available on the Checkmate website for approximately 90 days after the event. About Checkmate Pharmaceuticals Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on...

Continue reading

Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors

Ms. Williams-Brinkley brings more than 35 years of executive leadership experience in healthcare to the Travere Board SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the appointment of Ruth Williams-Brinkley to the Company’s Board of Directors, effective immediately. Ms. Williams-Brinkley brings to Travere more than 35 years of executive leadership in care delivery and health plan operations. “On behalf of the Board of Directors, I am pleased to welcome Ruth to Travere,” said Gary Lyons, chairman of the Travere Therapeutics Board of Directors. “She is a distinguished leader with extensive experience in the delivery of care and is an actively engaged and admired community leader. As we look to future potential commercial launches from our pipeline, Ruth’s insights will be instrumental...

Continue reading

Lydall Announces September 14, 2021 Special Meeting Results

Merger Agreement with Unifrax approved by Lydall ShareholdersLydall and Unifrax anticipate closing within 30 daysMANCHESTER, Conn., Sept. 14, 2021 (GLOBE NEWSWIRE) — Lydall, Inc. (NYSE:LDL, “Lydall” or “the Company”), a leading global provider of specialty filtration and advanced materials solutions, announced today the results of the special shareholder meeting held earlier today. At the special meeting, Lydall shareholders approved the transactions contemplated by that certain Merger Agreement dated June 21, 2021 by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc., and Unifrax I, LLC. Holders of approximately 77.5% of Lydall common stock voted to approve the merger. A total of 14,021,456 common shares of the 18,037,202 common shares issued and outstanding at the record date were voted at the Meeting,...

Continue reading

BayFirst Financial Corp. Announces Amendment to Increase its Stock Repurchase Program

ST. PETERSBURG, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (f/k/a First Home Bancorp, Inc.) (OTCQX: FHBI) (“BayFirst” or the “Company”), parent company of First Home Bank, today announced that its board of directors amended its stock repurchase program, initially authorized on January 26, 2021 for the repurchase of up to $100,000 per calendar quarter of the company’s issued and outstanding common stock, to allow the Company to repurchase up to $400,000 per quarter. The changes to the program will be implemented in the third quarter of 2021 and will continue until the earlier of the date an aggregate of $1,000,000 of common stock has been repurchased, with no more than $400,000 being bought back in one quarter, or October 1, 2022, or termination of the program by the board of directors. In addition to the increase...

Continue reading

Uniti Group Inc. to Present at the Goldman Sachs 30th Annual Communacopia Conference

LITTLE ROCK, Ark., Sept. 14, 2021 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, is scheduled to participate at the Goldman Sachs 30th Annual Communacopia Conference. The presentation is scheduled for 12:25 PM ET on September 23, 2021. You may access a live webcast of the virtual event on Uniti’s website at www.uniti.com under the Investors tab. The webcast will be available for replay for a limited time on Uniti’s website following the presentation. ABOUT UNITI Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of fiber and other wireless solutions for the communications industry. As of June 30, 2021, Uniti...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.